MedImmune Ventures
North America, Maryland, United States, Gaithersburg
Description
MedImmune Ventures invests in early to late stage, public and private biotechnology companies.
Investor Profile
MedImmune Ventures has made 47 investments, with 0 in the past 12 months and 17% as lead.
Stage Focus
- Series B (28%)
- Series A (26%)
- Series C (19%)
- Series D (13%)
- Series Unknown (11%)
- Debt Financing (2%)
- Seed (2%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Therapeutics
- Health Diagnostics
- Biopharma
- Clinical Trials
- Developer Platform
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
